Willow Bioscience is a synthetic biology company, rooted in innovative cannabinoid production.
Our multidisciplinary team of world-leading discovery biologists, biochemists and geneticists is dedicated to harnessing the therapeutic potential of plants. We provide pure, consistent, and cost-effective production processes for our pharmaceutical partners developing treatments for a wide array of medical conditions, from PTSD to Parkinson's.
We are pioneers in the biotechnology sector and have developed the only fully-integrated synthetic biology solution for opiate biosynthesis. We are now leveraging our unique design-build process--and our proven track record--to the biosynthesis of cannabinoids.
President and Chief Executive Officer and Director
Mr. Peters is an experienced executive having co-founded four start-up companies in the past 15 years. Mr. Peters has raised over $1.0 billion in equity and debt financings at various stages of corporate development and has been integral to successful transactions totalling over $4.0 billion on sale. Mr. Peters previously was Chief Financial Officer at Caracal Energy Inc., which sold to Glencore plc in 2014 for $1.8 billion.
Chief Financial Officer
Mr. Doupe has over 18 years’ experience in financial leadership roles, principally in the international oil and gas industry, during which time he provided corporate strategic direction while overseeing all aspects of financial operations, including budgeting and planning, treasury, accounting, tax, reporting and investor relation functions. Over half of Mr. Doupe’s 18 years of financial experience has been in various Chief Financial Officer roles, principally in publicly listed companies. Mr. Doupe is the Treasurer and a member of the Board of Directors of the Canada Council for the Americas – Alberta and holds a CA-CPA designation and a Bachelor of Management degree from the University of Calgary.
Dr. Peter Facchini
Chief Scientific Officer
Dr. Facchini has been Professor of Plant Biochemistry in the Department of Biological Sciences at the University of Calgary since 1995. Dr. Facchini is the Canada Research Chair in Plant Metabolic Processes Biotechnology and he received the C.D. Nelson Award from the Canadian Society of Plant Physiologists as the outstanding young plant biologist in Canada. Dr. Facchini has published over 150 research papers and scholarly articles in high-impact journals such as Nature Chemical Biology, Plant Cell, Plant Journal and the Journal of Biological Chemistry. Dr. Facchini received a PhD from the University of Toronto in 1991 and conducted postdoctoral research at the University of Kentucky and the Université de Montréal.
News and Press Releases